Hydrochlorothiazide, telmisartan
Sold as Co-micardis, Co-pritor, Tremistan plus, Telpres plus, Co-mizart, Telgen co, Telstan plus
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 5
- Registrations
- 17
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Ingelheim Pharmaceuticals (Pty) Ltd û Ferndale | Co-micardis, Co-pritor | 40/12,5 mg, 80/12,5 mg | 350096, 350097, 350347, 350348 | S3 | None |
| Sandoz South Africa (Pty) Ltd | Tremistan plus, Telpres plus | 40/12,5 mg, 80/12,5 mg, 80/25 mg | 460927, 460928, 460929, 460930.927, 460931.928, 460932.929 | S3 | None |
| Innovata pharmaceuticals | Co-mizart | 40/12,5, 80/12,5 | 490567, 490568 | S3 | None |
| Ranbaxy (SA) (Pty) Ltd1 of 2 cancelled | Telgen co | 40/12,5, 80/12,5 | 491020, 491021 | S3 | None |
| Activo Health (Pty) Ltd | Telstan plus | 40/12.5 mg, 80/12.5 mg, 80/25 mg | 510178, 510179, 510180 | S3 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Co-micardis 40/12,5 MG EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,50 mg TELMISARTAN 40,0 mg | 40/12,5 mg | 35009635/7.1.3/0096 | Registered | S3 | None |
| Co-micardis 80/12,5 MG EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5 mg TELMISARTAN 80,0 mg | 80/12,5 mg | 35009735/7.1.3/0097 | Registered | S3 | None |
| Co-pritor 40/12,5 MG EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5 mg TELMISARTAN 40,0 mg | 40/12,5 mg | 35034735/7.1.3/0347 | Registered | S3 | None |
| Co-pritor 80/12,5 MG EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5 mg TELMISARTAN 80,0 mg | 80/12,5 mg | 35034835/7.1.3/0348 | Registered | S3 | None |
| Tremistan plus 40/12,5 MG EACH TABLET CONTAINS: HYDROCHLOROTHIAZIDE 12,5 mg, TELMISARTAN 40,0 mg | 40/12,5 mg | 46092746/7.1.3/0927 | Registered | S3 | None |
| Tremistan plus 80/12,5 MG EACH TABLET CONTAINS :HYDROCHLOROTHIAZIDE 12,5 mg ,TELMISARTAN 80,0 mg | 80/12,5 mg | 46092846/7.1.3/0928 | Registered | S3 | None |
| Tremistan plus 80/25 MG EACH TABLET CONTAINS :HYDROCHLOROTHIAZIDE 25,0 mg, TELMISARTAN 80,0 mg | 80/25 mg | 46092946/7.1.3/0929 | Registered | S3 | None |
| Telpres plus 40/12,5 MG EACH TABLET CONTAINS :HYDROCHLOROTHIAZIDE 12,5 mg, TELMISARTAN 40,0 mg | 40/12,5 mg | 460930.92746/7.1.3/0930.927 | Registered | S3 | None |
| Telpres plus 80/12,5 MG EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5 mg TELMISARTAN 80,0 mg | 80/12,5 mg | 460931.92846/7.1.3/0931.928 | Registered | S3 | None |
| Telpres plus 80/25 MG EACH TABLET CONTAINS :HYDROCHLOROTHIAZIDE 25,0 mg, TELMISARTAN 80,0 mg | 80/25 mg | 460932.92946/7.1.3/0932.929 | Registered | S3 | None |
| Co-mizart 40/12,5 EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5mg and TELMISARTAN 40,0 mg | 40/12,5 | 49056749/7.1.3/0567 | Registered | S3 | None |
| Co-mizart 80/12,5 EACH TABLET CONTAINS HYDROCHLOROTHIAZIDE 12,5 mg ,TELMISARTAN 80,0 mg | 80/12,5 | 49056849/7.1.3/0568 | Registered | S3 | None |
| Telgen co 40/12,5 EACH TABLET CONTAINS: TELMISARTAN 40,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 40/12,5 | 49102049/7.1.3/1020 | Registered | S3 | None |
| Telgen co 80/12,5 EACH TABLET CONTAINS: TELMISARTAN 80,0 mg HYDROCHLOROTHIAZIDE 12,5 mg | 80/12,5 | 49102149/7.1.3/1021 | Cancelled | S3 | None |
| Telstan plus 40/12.5 MG Each uncoated Tablet contains: Telmisartan 40,0 mg; Hydrochlorothiazide 12,5 mg | 40/12.5 mg | 51017851/7.1.3/0178 | Registered | S3 | None |
| Telstan plus 80/12.5 MG Each uncoated Tablet contains: Telmisartan 80,0 mg; Hydrochlorothiazide 12,5 mg | 80/12.5 mg | 51017951/7.1.3/0179 | Registered | S3 | None |
| Telstan plus 80/25 MG Each uncoated Tablet contains: Telmisartan 80,0 mg; Hydrochlorothiazide 25,0 mg | 80/25 mg | 51018051/7.1.3/0180 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence medium.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Hydrochlorothiazide, telmisartan
S3: Hydrochlorothiazide
Consolidated Schedules 06 July 2026, line 3721
S3: Telmisartan
Consolidated Schedules 06 July 2026, line 4286
Pharmacological class: Other hypotensives. (class 7.1.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.